HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Radiation definitely improves survival in early endometrial cancer

Adjuvant radiation therapy improves overall and relative survival in women with stage I endometrial adenocarcinoma, according to the largest reported population analysis conducted to date.

Adjuvant radiation therapy improves overall and relative survival in women with stage I endometrial adenocarcinoma, according to the largest reported population analysis conducted to date.

Researchers from Utah conducted a retrospective analysis using data on over 21,000 patients with stage IA-C node-negative disease from the Surveillance, Epidemiology, and End Results program of the US National Cancer Institute.

They calculated the 5-year overall survival rates for patients younger than age 56, 56 to 75, and those older than age 75 receiving radiation versus those not receiving radiation to be 98% versus 88%, 94% versus 85%, and 84% versus 67%, respectively. Ten-year overall survival rates for the same groups were 92% versus 69%, 76% versus 72%, and 59% versus 42%, respectively.

In addition, radiation therapy produced statistically significant improvements in relative survival of stage IC/grade 1 and stage IC/grades 3 and 4 disease (HR 0.44; 95% CI; 0.31–0.63; P<0.001 and HR 0.72; 95% CI; 0.57–0.92; P=0.009, respectively).

Lee CM, Szabo A, Shrieve DC, et al. Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma. JAMA. 2006;295:389-397.